Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Characteristics of patients shifted toward to high category in Ca level during the 3-month intervalsM-L and M-M groupsM-H groupSMDDemographics Age, years62.0 ± 20.260.8 ± 19.60.06 Sex, female, %36.540.40.15 Body mass index, kg/m221.5 ± 5.721.4 ± 5.60.01 Cause of end-stage kidney disease, % Glomerulonephritis39.346.6 Diabetic nephropathy29.422.60.17 Others31.430.8Comorbidities, % Diabetes mellitus36.928.50.18 Cardiovascular diseases58.657.80.02 Lung diseases7.27.00.01 Liver diseases12.813.80.03 Malignancies4.74.10.03Dialysis Log duration of dialysis, years0.7 ± 0.70.7 ± 12.60.14 Kt/V, single pool1.4 ± 0.51.5 ± 0.50.07 Dialysate calcium, mEq/L2.7 ± 0.42.8 ± 0.40.03Laboratory data Albumin, g/dL3.7 ± 0.53.7 ± 0.50.00 Hemoglobin, g/dL10.5 ± 1.810.6 ± 1.80.05MBD-related characteristics Serum parameters P, mg/dL5.4 ± 2.25.6 ± 2.20.09 Log iPTH, pg/mL2.3 ± 0.52.3 ± 0.50.05 History of parathyroidectomy, %4.46.20.08 Prescription of MBD-related agents, % VDRAs79.886.40.22 Intravenous45.355.4 Oral34.531.0 Phosphate binders85.889.50.16 Both26.431.4 Non: Ca-based15.017.3 Ca-based44.440.7 Cinacalcet19.328.20.21Values are presented as mean ± standard deviation for continuous variables and proportions for categorical variablesCa Calcium, H High, iPTH Intact parathyroid hormone, L Low, M Middle, MBD Mineral and bone disorder, P Phosphorus, SMD Standard mean difference, VDRA Vitamin D receptor activator

Source: Serum calcium. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This study was designed as a case-cohort study; 40% of the whole cohort (n = 3276) was randomly selected into a subcohort, from which data were collected prospectively (Fig.

Source: Methods.

From 86 facilities, all 8,229 dialysis patients with secondary hyperparathyroidism were registered and 3,276 patients were selected into the subcohort.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Changes in 3-month mineral and bone disorder patterns were associated with all-cause mortality in prevalent hemodialysis patients with secondary hyperparathyroidism

Cohort study · BMC Nephrology · 2020

Original publication title

Changes in 3-month mineral and bone disorder patterns were associated with all-cause mortality in prevalent hemodialysis patients with secondary hyperparathyroidism

Chihiro Kato; Naohiko Fujii; Chisato Miyakoshi; Shinji Asada; Yoshihiro Onishi; Shingo Fukuma; Takanobu Nomura; Michihito Wada; Masafumi Fukagawa; Shunichi Fukuhara; Tadao Akizawa

© The Author(s) 2020

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Changes in the 3-month patterns of phosphorus and calcium toward the middle category were associated with lower mortality. Our study also suggests the importance of avoiding hypercalcemia.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

There is limited evidence on the association between short-term changes in mineral and bone disorder parameters and survival in maintenance hemodialysis patients.

Source: Background

Abstract: What methods does the paper describe?

We investigated the association between changing patterns of phosphorus, calcium and intact parathyroid hormone levels and all-cause mortality in hemodialysis patients with secondary hyperparathyroidism. Each parameter was divided into three categories (low [L], middle [M] and high [H]), and the changing patterns between two consecutive visits at 3-month intervals were categorized into nine groups (e.g., L-L and M-H). The middle category was defined as 4.0 to 7.0 mg/dL for phosphorous, 8.5 to 9.5 mg/dL for calcium and 200 to 500 pg/mL for intact parathyroid hormone. Adjusted incidence rates and rate ratios were analyzed by weighted Poisson regression models accounting for time-dependent exposures.

Source: Methods

Abstract: Results

For phosphorus, shifts from low/high to middle category (L-M/H-M) were associated with a lower mortality compared with the L-L and H: H groups, whereas shifts from middle to low/high category (M-L/M-H) were associated with a higher mortality compared with the M-M group. For calcium, shifts from low/middle to high category (L: H/M-H) were associated with a higher mortality compared with the L-L and M-M groups, whereas shifts from high to middle category (H-M) were associated with a lower mortality compared with the H: H group.

For intact parathyroid hormone, shifts from low to middle category (L-M) were associated with a lower mortality compared with the L-L group.

Source: Results

Abstract: Conclusions

Changes in the 3-month patterns of phosphorus and calcium toward the middle category were associated with lower mortality. Our study also suggests the importance of avoiding hypercalcemia.

Source: Conclusions
Authors’ abstract

Background

There is limited evidence on the association between short-term changes in mineral and bone disorder parameters and survival in maintenance hemodialysis patients.

Methods

We investigated the association between changing patterns of phosphorus, calcium and intact parathyroid hormone levels and all-cause mortality in hemodialysis patients with secondary hyperparathyroidism. Each parameter was divided into three categories (low [L], middle [M] and high [H]), and the changing patterns between two consecutive visits at 3-month intervals were categorized into nine groups (e.g., L-L and M-H). The middle category was defined as 4.0 to 7.0 mg/dL for phosphorous, 8.5 to 9.5 mg/dL for calcium and 200 to 500 pg/mL for intact parathyroid hormone. Adjusted incidence rates and rate ratios were analyzed by weighted Poisson regression models accounting for time-dependent exposures.

Results

For phosphorus, shifts from low/high to middle category (L-M/H-M) were associated with a lower mortality compared with the L-L and H: H groups, whereas shifts from middle to low/high category (M-L/M-H) were associated with a higher mortality compared with the M-M group. For calcium, shifts from low/middle to high category (L: H/M-H) were associated with a higher mortality compared with the L-L and M-M groups, whereas shifts from high to middle category (H-M) were associated with a lower mortality compared with the H: H group.

For intact parathyroid hormone, shifts from low to middle category (L-M) were associated with a lower mortality compared with the L-L group.

Conclusions

Changes in the 3-month patterns of phosphorus and calcium toward the middle category were associated with lower mortality. Our study also suggests the importance of avoiding hypercalcemia.

Publication and source details

Original title: Changes in 3-month mineral and bone disorder patterns were associated with all-cause mortality in prevalent hemodialysis patients with secondary hyperparathyroidism

Chihiro Kato; Naohiko Fujii; Chisato Miyakoshi; Shinji Asada; Yoshihiro Onishi; Shingo Fukuma; Takanobu Nomura; Michihito Wada; Masafumi Fukagawa; Shunichi Fukuhara; Tadao Akizawa

BMC Nephrology · 2020

© The Author(s) 2020https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T14:25:19.921477+00:00

DOI: 10.1186/s12882-020-02088-x · PMC7552558